Drug-induced autoimmune hepatitis associated with turmeric Detary supplement use

Ashley L. Lukefahr, Sean McEvoy, Chelsea Alfafara, Janet L. Funk

Research output: Contribution to journalArticlepeer-review

30 Scopus citations


Turmeric Detary supplement sales, which accounted for US$69 million in spenDng in 2016, have been increasing exponentially in the USA, making this one of the most popular botanical supplements sold in the USA. Herbal supplement use, which is generally regarded as safe by consumers, is not usually reported to healthcare providers. We reported here on a case of autoimmune hepatitis, occurring in a 71-year-old woman taking turmeric Detary supplements for the maintenance of carDovascular health, which resolved rapidly following Dscontinuation of the turmeric supplements. Of particular note, turmeric use was not documented in the patient's meDcal records and the potential causative role of the turmeric supplementation was ultimately identified by the patient rather than the healthcare providers. To our knowledge, this is the first documented report of turmeric supplement-induced autoimmune hepatitis.

Original languageEnglish (US)
Article numberbcr-2018-224611
JournalBMJ case reports
StatePublished - 2018


  • complementary meDcine
  • contrainDcations and precautions
  • gastrointestinal system
  • healthcare improvement and patient safety
  • hepatitis other

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Drug-induced autoimmune hepatitis associated with turmeric Detary supplement use'. Together they form a unique fingerprint.

Cite this